Related Experiment Video

Updated: Jun 8, 2026

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells
09:06

Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells

Published on: December 19, 2025

Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases

Merouane Bencherif1, Patrick M Lippiello, Rudolf Lucas

  • 1Preclinical Research, Targacept, Inc., Winston-Salem, NC 27101, USA. Merouane.Bencherif@Targacept.com

Cellular and Molecular Life Sciences : CMLS
|October 19, 2010
PubMed

Insights

Runaway inflammation drives many diseases. Targeting the cholinergic anti-inflammatory pathway via alpha7 nicotinic acetylcholine receptors offers a novel therapeutic strategy by modulating cytokines, potentially treating numerous inflammatory conditions.

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Cytokine-mediated inflammation is implicated in numerous debilitating diseases, including type 2 diabetes, arthritis, and asthma.
  • Current therapies often target specific cytokines like TNF-α, but their temporospatial changes remain poorly understood.
  • The cholinergic anti-inflammatory pathway presents an alternative therapeutic avenue.

Purpose of the Study:

  • To explore the therapeutic potential of targeting the alpha7 nicotinic acetylcholine receptor (α7 nAChR) for anti-inflammatory effects.
  • To investigate the modulation of proinflammatory cytokines through cholinergic mechanisms.

Main Methods:

  • Review of preclinical studies investigating the cholinergic anti-inflammatory pathway.
  • Analysis of the role of α7 nAChR expressed on macrophages and immune cells.

Main Results:

  • Preclinical studies demonstrate the therapeutic potential of modulating proinflammatory cytokines via the α7 nAChR.
  • The cholinergic anti-inflammatory pathway utilizes cholinergic mechanisms to regulate immune responses.

Conclusions:

  • Targeting the cholinergic anti-inflammatory pathway via α7 nAChR modulation offers a promising alternative to cytokine inhibition.
  • Successful translation to human efficacy could yield new therapies for a wide range of inflammatory diseases.

More Related Videos

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

Related Concept Videos

Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
Cholinergic Receptors: Muscarinic01:25

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine. 
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+. Activation...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inflammation: Introduction01:28

Inflammation: Introduction

Inflammation is a fundamental, protective biological response of vascularized tissues to cellular injury, infection, or harmful stimuli. Its primary function is to eliminate the initial cause of injury, clear necrotic cells and damaged tissue, and initiate the necessary repair processes.Cardinal SignsAcute inflammation presents with classic signs. Redness results from vasodilation and increased blood flow. Heat is due to increased metabolism and circulation. Swelling results from the...